Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Carboxylic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101781197B reveals a high-yield route for chiral binaphthyl dicarboxylic acid. Achieve >99% optical purity without chromatography for cost-effective supply.
Novel Ni-catalyzed route for chiral nafoxidine-3-carboxylic acid. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113896662A details a high-yield rhodium-catalyzed synthesis for chiral aminocyclopropane intermediates, offering significant cost and supply chain advantages.
Discover a scalable synthesis route for chiral binaphthalene dicarboxylic acid via patent CN101781197A. Achieve >99% optical purity and significant cost reduction in pharma intermediate manufacturing.
Patent CN113185439B reveals scalable chiral ligand synthesis reducing costs and enhancing supply chain reliability for complex pharmaceutical manufacturing processes.
Solve chiral purity challenges in halichondrin synthesis. Our CDMO expertise delivers >99% ee intermediates with 92% yield, reducing impurity risks for oncology drug development.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.